why choose us

First received: March 10, 2023

Clinical Trial: Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Colorectal Cancer

Study Type: INTERVENTIONAL


Official Title: Adaptive, Individualized Dose Escalation of Fluorouracil-Based Chemotherapy for Gastrointestinal Cancer: Pilot Study of the FOX Regimen

Brief Summary: This is a single-arm clinical trial that will evaluate the feasibility of a chemotherapy regimen adaptive, individualized dose escalation of 5-FU chemotherapy for patients who have good tolerance of the initial dose.Study participants will also receive oxaliplatin chemotherapy together with 5-FU, at standard doses.The goal of the study is to examine the feasibility and effectiveness of this approach, using individualized dose escalation of 5-FU in patients who do not have serious side effects at lower doses.

Read more